A distinct expression pattern of the long 3′-untranslated region dicer mRNA and its implications for posttranscriptional regulation in colorectal cancer

Clinical and Translational Gastroenterology

Volumn 3, Issue , 2012, Pages

  Hamaya, Yasushi ^a   Kuriyama, Shigeru ^a   Takai, Tetsunari ^b   Yoshida, Ken Ichi ^c   Yamada, Takanori ^a   Sugimoto, Mitsushige ^a   Osawa, Satoshi ^a   Sugimoto, Ken ^a   Miyajima, Hiroaki ^a   Kanaoka, Shigeru ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

^c Hokuto Wakaba Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; MESSENGER RNA; MICRORNA; MICRORNA 103; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; GENE FUNCTION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYADENYLATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR LOCALIZATION;

EID: 84864444427     PISSN: None     EISSN: 2155384X     Source Type: Journal    
DOI: 10.1038/ctg.2012.12     Document Type: Article

References (39)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Iorio MV, Croce CM. MicroRNAs in cancer: Small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856.
3. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
4. Lu J, Getz G, Miska EA et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
5. Lin R-J, Lin Y-C, Chen J et al. MicroRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res 2010; 70: 7841-7850.
6. Suzuki H, Takatsuka S, Akashi H et al. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Res 2011; 71: 5646-5658.
7. Sureban SM, May R, Ramalingam S et al. Selective blockade of DCAMKL-1 results in tumor growth arrest by a let-7a microRNA-dependent mechanism. Gastroenterology 2009; 137: 649-659.
8. Strillacci A, Griffoni C, Sansone P et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 2009; 315: 1439-1447.
9. Schetter AJ, Leung SY, Sohn JJ et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425-436.
10. Carmichael JB, Provost P, Ekwall K et al. Ago1 and Dcr1, two core components of the RNA interference pathway, functionally diverge from Rdp1 in regulating cell cycle events in Schizosaccharomyces pombe. Mol Biol Cell 2004; 15: 1425-1435.
11. Cheng C, Fu X, Alves P et al. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol 2009; 10: R90.
12. Faber C, Horst D, Hlubek F et al. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011; 47: 1414-1419.
13. Stratmann J, Wang CJ, Gnosa S et al. Dicer and miRNA in relation to clinicopathological variables in colorectal cancer patients. BMC Cancer 2011; 11: 345.
14. Tokumaru S, Suzuki M, Yamada H et al. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 2008; 29: 2073-2077.
15. Mayr C, Bartel DP. Widespread shortening of 30UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009; 138: 673-684.
16. Martello G, Rosato A, Ferrari F et al. A microRNA targeting Dicer for metastasis control. Cell 2010; 141: 1195-1207.
17. Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev 1997; 11: 2755-2766.
18. Proudfoot N. Poly(A) signals. Cell 1991; 64: 671-674.
19. Beaudoing E, Gautheret D. Identification of alternate polyadenylation sites and analysis of their tissue distribution using EST data. Genome Res 2001; 11: 1520-1526.
20. Tian B, Hu J, Zhang HB et al. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucl Acids Res 2005; 33: 201-212.
21. Sandberg R, Neilson JR, Sarma A et al. Proliferating cells express mRNAs with shortened 30 untranslated regions and fewer microRNA target sites. Science 2008; 320: 1643-1647.
22. Singh P, Alley TL, Wright SM et al. Global changes in processing of mRNA 30 Untranslated regions characterize clinically distinct cancer subtypes. Cancer Res 2009; 69: 9422-9430.
23. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351-379.
24. Sobin LH, Wittekind C. Intenational Union Against Cancer (UICC). TNM Classification of Malignant Tumors 6th edn John Wiley & Sons, Inc: New York, 2002.
25. Dydensborg AB, Herring E, Auclair J et al. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1067-G1074.
26. Chiosea S, Jelezcova E, Chandran U et al. Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006; 169: 1812-1820.
27. Sugito N, Ishiguro H, Kuwabara Y et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-7328.
28. Jakymiw A, Patel RS, Deming N et al. Overexpression of Dicer as a result of reduced let-7 microRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 2010; 49: 549-559.
29. Grelier G, Voirin N, Ay AS et al. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009; 101: 673-683.
30. Merritt WM, Lin YG, Han LY et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008; 359: 2641-2650.
31. Karube Y, Tanaka H, Osada H et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 2005; 96: 111-115.
32. Chiosea S, Acquafondata M, Luo J et al. DICER1 and PRKRA in colon adenocarcinoma. Biomark Insights 2008; 3: 253-258.
33. Papachristou DJ, Korpetinou A, Giannopoulou E et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 2011; 459: 431-440.
34. Young J, Leggett B, Ward M et al. Frequent loss of heterozygosity on chromosome-14 occurs in advanced colorectal carcinomas. Oncogene 1993; 8: 671-675.
35. Chiosea S, Jelezcova E, Chandran U et al. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007; 67: 2345-2350.
36. Lau AG, Irier HA, Gu JP et al. Distinct 30 UTRs differentially regulate activity-dependent translation of brain-derived neurotrophic factor (BDNF). Proc Natl Acad Sci USA 2010; 107: 15945-15950.
37. Ji Z, Luo W, Li W et al. Transcriptional activity regulates alternative cleavage and polyadenylation. Mol Syst Biol 2011; 7: 543.
38. Cummins JM, He YP, Leary RJ et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-3692.
39. Kumar MS, Pester RE, Chen CY et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23: 2700-2704.